MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effectiveness of Deep Brain Stimulation (DBS) in Mice with Spinocerebellar Ataxia (SCA1).

V. Vedam-Mai, K. McFarland, R. Nathu, S. Kurtovic, Q. Zhang, T. Ashizawa, M. Okun (Gainesville, FL, USA)

Meeting: 2017 International Congress

Abstract Number: 799

Keywords: Ataxia: Treatment, Deep brain stimulation (DBS)

Session Information

Date: Wednesday, June 7, 2017

Session Title: Ataxia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To evaluate the effectiveness of Deep Brain Stimulation (DBS) in a mouse model of Spinocerebellar Ataxia type 1 (SCA1).

Background: Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominantly inherited neurodegenerative disorder resulting in Purkinje cell loss and atrophy of the brainstem and cerebellum. There is no cure for SCA1 and typically, symptoms worsen over time and death results from complications related to brainstem dysfunction. An absence of the inhibitory signals to the deep cerebellar nuclei (DCN) is postulated to result in hyperexcitability and disinhibition of DCN neurons thereby affecting the cerebellar-thalamic-cortical pathways. Regulating firing frequency of DCN neurons could potentially ameliorate symptoms of the disease. We hypothesize that DBS can be used to alleviate ataxia in SCA1 mice. 

Methods: Symptomatic B05/SCA1 mice were stereotactically implanted in the DCN with stainless steel, single channel, DBS electrodes (Plastics One). Mice in the experimental “STIM” group underwent acute High Frequency Stimulation (HFS) for one week post recovery and mice in the “SHAM” group did not undergo any HFS. Mice were tested for improvements in gait by comparing gait signal before DBS implantation, after DBS implantation and again after HFS. At the end of the experimental paradigm, mice were sacrificed, brains dissected and flash frozen for transcriptomic analyses to assess gene expression changes occurring from HFS. 

Results: We were able to implant DBS electrodes in DCN of B05 mice and perform acute HFS. Gait assessment of movement control and coordination demonstrated improvements in the experimental group of mice following HFS DBS. Hind paw area and power generation of the hind paw during propulsion (MAX dA/dT) was returned to values similar to wild-type siblings. This implies that our treatment at least corrects B05 mice for their lack of control and deceleration. Transcriptomic analysis is ongoing.

 

Conclusions: In this study, we were able to target the deep cerebellar nucleus in ataxic mice with DBS electrodes and perform acute HFS. We demonstrate improvement in the gait of stimulated animals. Further work including chronic stimulation paradigms will be necessary to confirm our initial observations in order to translate this therapy to humans.

To cite this abstract in AMA style:

V. Vedam-Mai, K. McFarland, R. Nathu, S. Kurtovic, Q. Zhang, T. Ashizawa, M. Okun. Effectiveness of Deep Brain Stimulation (DBS) in Mice with Spinocerebellar Ataxia (SCA1). [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/effectiveness-of-deep-brain-stimulation-dbs-in-mice-with-spinocerebellar-ataxia-sca1/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effectiveness-of-deep-brain-stimulation-dbs-in-mice-with-spinocerebellar-ataxia-sca1/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley